(Reuters) A pioneering -- but much delayed -- cannabis-based medicine for multiple sclerosis is now on track to win regulatory approval in Britain and Spain in the second quarter of 2010, its maker said on Thursday.
[Click the title, above, to post a comment.]
0 comments:
Post a Comment
Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.